Cutaneous melanomas attributable to ultraviolet radiation exposure by state.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
01 09 2020
Historique:
received: 14 12 2019
accepted: 24 01 2020
pubmed: 18 2 2020
medline: 7 4 2021
entrez: 18 2 2020
Statut: ppublish

Résumé

Information on cutaneous melanoma (melanoma) burden attributable to ultraviolet (UV) radiation by state could inform state and local public health policies to mitigate the burden. We estimated numbers, proportions and age-standardized incidence rates of malignant melanomas attributable to UV radiation in each US state by calculating the difference between observed melanomas during 2011-2015 and expected cases based on historically low incidence rates among whites in Connecticut from 1942 to 1954. The low melanoma burden in Connecticut during this period likely reflected UV exposure accumulated in the 1930s or earlier, when exposure was likely minimized by clothing style and limited recreational exposure. The estimated number of melanoma cases attributable to UV exposure during 2011-2015 in the United States was 338,701, or 91.0% of the total cases (372,335); 94.3% (319,412) of UV-attributable cases occurred in non-Hispanic whites. By state, the attributable proportion among non-Hispanic whites ranged from 87.6% in the District of Columbia to 97.3% in Hawaii. The attributable age-standardized rate (per 100,000) among non-Hispanic whites ranged from 15.1 (95% CI, 13.4-16.7) in Alaska to 65.1 (95% CI, 61.4-68.9) in Hawaii and was ≥23.3 in half of states. Considerable proportions and incidence rates of melanoma attributable to UV radiation in all states underscores the need for broad implementation or enforcement of preventive measures across states, with priority for states with higher burden.

Identifiants

pubmed: 32064604
doi: 10.1002/ijc.32921
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1385-1390

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 UICC.

Références

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019;69:7-34.
Thrift AP, Gudenkauf FJ. Melanoma incidence among non-Hispanic whites in all 50 United States from 2001 through 2015. J Natl Cancer Inst 2019, Jul 25, pii: djz153. https://doi.org/10.1093/jnci/djz153 [Epubahead of print].
Rahib L, Smith BD, Aizenberg R, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014;74:2913-21.
Guy GP Jr, Machlin SR, Ekwueme DU, et al. Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. Am J Prev Med 2015;48:183-7.
US Department of Health and Human Services. The Surgeon General's call to action to prevent skin cancer. Gaps in Research and Surveillance. Washington, DC: Office of the Surgeon General (US), 2014.
Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin 2018;68:31-54.
Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res 1993;3:395-401.
U.S. Department of Health and Human Services. The Surgeon General's call to action to prevent skin cancer. Washington, DC: U.S. Department of Health and Human Services, Office of the Surgeon General, 2014.
Forty-five years of cancer incidence in Connecticut: 1935-79. Natl Cancer Inst Monogr 1986;70:1-706.
Parkin DM, Mesher D, Sasieni P. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010. Br J Cancer 2011;105(Suppl 2):S66-9.
Arnold M, de Vries E, Whiteman DC, et al. Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012. Int J Cancer 2018;143:1305-14.
CDC/NCI. National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database: USCS Incidence Analytic Database 1998-2015. Washington, DC: United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, 2017.
Gloster HM Jr, Neal K. Skin cancer in skin of color. J Am Acad Dermatol 2006;55:741-60. quiz 61-4.
WHO. Manual of the international statistical classification of diseases, injuries, and causes of death, 1975, 9th revision, vol. 1. Geneva, Switzerland: World Health Organization, 1977.
Gibson C, Jung KJ. Historical census statistics on population totals by race, 1790 to 1990, and by Hispanic origin, 1790 to 1990, for the United States, regions, divisions, and states. U.S. Census Bureau, Population Division Working Paper No. 56, 2002. Suitland-Silver Hill, MD: U.S. Census Bureau, 2005.
Eisenberg H, Campbell PC, Flannery JT. Cancer in Connecticut: Incidence characteristics 1935-1962. Connecticut State Department of Health: Hartford, CT, 1967.
American Cancer Society. Cancer Statistics Center. Available from http://cancerstatisticscenter.cancer.org. Accessed September 20, 2019.
Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005;41:45-60.
Varedi A, Secrest AM, Harding G, et al. Comprehensive outreach, prevention education, and skin cancer screening for Utah ski resorts. Dermatol Online J 2018;24:13030.
O'Riordan DL, Steffen AD, Lunde KB, et al. A day at the beach while on tropical vacation: sun protection practices in a high-risk setting for UV radiation exposure. Arch Dermatol 2008;144:1449-55.
Ragan KR, Buchanan Lunsford N, Thomas CC, et al. Skin cancer prevention behaviors among agricultural and construction Workers in the United States, 2015. Prev Chronic Dis 2019;16:E15.
Whiteman DC, Stickley M, Watt P, et al. Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol 2006;24:3172-7.
United States Environmental Protection Agency. Sun safety monthly average UV index. Avaliable at: https://www.epa.gov/sunsafety/sun-safety-monthly-average-uv-index#tab-1. Accessed August 29, 2019.
Liu-Smith F, Farhat AM, Arce A, et al. Sex differences in the association of cutaneous melanoma incidence rates and geographic ultraviolet light exposure. J Am Acad Dermatol 2017;76:499-505.e3.
Fioletov VE, Kimlin MG, Krotkov N, et al. UV index climatology over the United States and Canada from ground-based and satellite estimates. J Geophys Res 2004;109:D22308.
Richards TB, Johnson CJ, Tatalovich Z, et al. Association between cutaneous melanoma incidence rates among white US residents and county-level estimates of solar ultraviolet exposure. J Am Acad Dermatol 2011;65:S50-7.
McKenzie R, Bodeker G, Scott G, et al. Geographical differences in erythemally-weighted UV measured at mid-latitude USDA sites. Photochem Photobiol Sci 2006;5:343-52.
Centers for Disease Control and Prevention. Sunburn prevalence among adults-United States, 1999, 2003, and 2004. MMWR Morb Mortal Wkly Rep 2007;56:524-8.
National Cancer Institute, Cancer trends progress report. Prevention: Sun-protective behavior; 2015. Available at: https://progressreport.cancer.gov/prevention/sun_protection. Accessed August 26, 2019.
Holman DM, Ding H, Guy GP Jr, et al. Prevalence of sun protection use and sunburn and Association of Demographic and Behaviorial Characteristics with Sunburn among US adults. JAMA Dermatol 2018;154:561-8.
Cokkinides VE, Weinstock MA, O'Connell MC, et al. Use of indoor tanning sunlamps by US youth, ages 11-18 years, and by their parent or guardian caregivers: prevalence and correlates. Pediatrics 2002;109:1124-30.
Geller AC, Colditz G, Oliveria S, et al. Use of sunscreen, sunburning rates, and tanning bed use among more than 10 000 US children and adolescents. Pediatrics 2002;109:1009-14.
Holman DM, Jones SE, Qin J, et al. Prevalence of indoor tanning among U.S. high school students from 2009 to 2017. J Community Health 2019;44:1086-9.
Lazovich D, Isaksson Vogel R, Weinstock MA, et al. Association between indoor tanning and melanoma in younger men and women. JAMA Dermatol 2016;152:268-75.
Qin J, Holman DM, Jones SE, et al. State indoor tanning Laws and Prevalence of indoor tanning among US high school students, 2009-2015. Am J Public Health 2018;108:951-6.
Guy GP Jr, Zhang Y, Ekwueme DU, et al. The potential impact of reducing indoor tanning on melanoma prevention and treatment costs in the United States: an economic analysis. J Am Acad Dermatol 2017;76:226-33.
National Conference of State Legislators. Indoor tanning restrictions for minors-A state-by-state comparison. Updated November 2, 2018. Available from http://www.ncsl.org/research/health/indoor-tanning-restrictions.aspx. Accessed September 3, 2019.
Stryker JE, Yaroch AL, Moser RP, et al. Prevalence of sunless tanning product use and related behaviors among adults in the United States: results from a national survey. J Am Acad Dermatol 2007;56:387-90.
Guy GP Jr, Watson M, Seidenberg AB, et al. Trends in indoor tanning and its association with sunburn among US adults. J Am Acad Dermatol 2017;76:1191-3.
Weinstock MA, Lott JP, Wang Q, et al. Skin biopsy utilization and melanoma incidence among Medicare beneficiaries. Br J Dermatol 2017;176:949-54.
Carter JL, Coletti RJ, Harris RP. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ 2015;350:g7773.
Wernli KJ, Henrikson NB, Morrison CC, et al. Screening for Skin Cancer in Adults: An Updated Systematic Evidence Review for the US Preventive Services Task Force. Rockville, MD: US Preventive Services Task Force, 2016.
U.S. Preventive Services Task Force, Grossman DC, Curry SJ, et al. Behavioral counseling to prevent skin cancer: US preventive services task force recommendation statement. JAMA 2018;319:1134-42.
Rogers HW, Weinstock MA, Feldman SR, et al. Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. population, 2012. JAMA Dermatol 2015;151:1081-6.
Sandhu PK, Elder R, Patel M, et al. Community-wide interventions to prevent skin cancer: two community guide systematic reviews. Am J Prev Med 2016;51:531-9.
Dono J, Ettridge KA, Sharplin GR, et al. The relationship between sun protection policies and practices in schools with primary-age students: the role of school demographics, policy comprehensiveness and SunSmart membership. Health Educ Res 2014;29:1-12.
Iannacone MR, Youlden DR, Baade PD, et al. Melanoma incidence trends and survival in adolescents and young adults in Queensland, Australia. Int J Cancer 2015;136:603-9.
Chin L, Garraway LA, Fisher DE. Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev 2006;20:2149-82.
Tsao H, Chin L, Garraway LA, et al. Melanoma: from mutations to medicine. Genes Dev 2012;26:1131-55.
Anderson WF, Pfeiffer RM, Tucker MA, et al. Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma. Cancer 2009;115:4176-85.
Pandiani C, Beranger GE, Leclerc J, et al. Focus on cutaneous and uveal melanoma specificities. Genes Dev 2017;31:724-43.
Hodis E, Watson IR, Kryukov GV, et al. A landscape of driver mutations in melanoma. Cell 2012;150:251-63.
Altieri L, Miller KA, Huh J, et al. Prevalence of sun protection behaviors in Hispanic youth residing in a high ultraviolet light environment. Pediatr Dermatol 2018;35:e52-4.
Jacobs EJ, Briggs PJ, Deka A, et al. Follow-up of a large prospective cohort in the United States using linkage with multiple state cancer registries. Am J Epidemiol 2017;186:876-84.

Auteurs

Farhad Islami (F)

Surveillance and Health Services Research Program, American Cancer Society, Atlanta, GA.

Ann Goding Sauer (AG)

Surveillance and Health Services Research Program, American Cancer Society, Atlanta, GA.

Kimberly D Miller (KD)

Surveillance and Health Services Research Program, American Cancer Society, Atlanta, GA.

Stacey A Fedewa (SA)

Surveillance and Health Services Research Program, American Cancer Society, Atlanta, GA.

Adair K Minihan (AK)

Surveillance and Health Services Research Program, American Cancer Society, Atlanta, GA.

Alan C Geller (AC)

Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, MA.

J Leonard Lichtenfeld (JL)

Office of Chief Medical and Scientific Officer, American Cancer Society, Atlanta, GA.

Ahmedin Jemal (A)

Surveillance and Health Services Research Program, American Cancer Society, Atlanta, GA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH